These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2551923)

  • 1. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
    Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
    J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
    Bostic JR; Brown KE; Young NS; Koenig S
    J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
    Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy.
    Chen MY; Hung CC; Fang CT; Hsieh SM
    Clin Infect Dis; 2001 May; 32(9):1361-5. PubMed ID: 11303273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
    Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
    Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
    Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
    Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia.
    Heegaard ED; Jensen L; Hornsleth A; Schmiegelow K
    Pediatr Hematol Oncol; 1999; 16(4):329-34. PubMed ID: 10407869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parvovirus B19 infections in Germany 1987-1988].
    Schwarz TF; Jäger G; Schlipköter UA; Wiersbitzky S; Tiller FW; Hottenträger B; Deinhardt F; Roggendorf M
    Offentl Gesundheitswes; 1990 Feb; 52(2):53-7. PubMed ID: 2158028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
    Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
    Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic of parvovirus B19 infection.
    Schwarz TF; Roggendorf M
    Behring Inst Mitt; 1990 Aug; (85):35-8. PubMed ID: 2171483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
    Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M
    J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
    Corcoran A; Crowley B; Dewhurst C; Pizer BL; Doyle S
    J Med Virol; 2006 Jan; 78(1):125-8. PubMed ID: 16299723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W; Halim MA; Al-Nakib W
    Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
    Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
    J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI; Enders M; Motz M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.